| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |